FDA Issues Notice on Side Effects of Asthma Drug

Jun 17th, 2009 | By Ed Wallis | Category: Pharmaceutical

Federal health regulators have issued a notice cautioning doctors about potential psychiatric side effects of the asthma drug Singulair and similar medicines. According to the Food and Drug Administration, drugs including Singulair, AstraZeneca Plc’s Accolate and Cornerstone Therapeutics Inc’s Zyflo and Zyflo CR may cause agitation, aggression, suicidal thinking, suicide, depression, insomnia and irritability. The FDA had previously announced that it was investigating a potential link between Singulair and suicidal behavior. [Reuters]

If you have experienced any of these issues, contact Ed Wallis today at (901) 527-2125.

Ed Wallis and other attorneys in his firm handle pharamaceutical litigaiton cases, to protect the rights of injured persons harmed by taking prescription drugs. For more information on how to recover from your injuries or to receive information about a medicine and pharmaceutical lawyer, or for information on filing a lawsuit for a prescription drug including Trasylol (used in heart surgery), Chantix (anti-smoking drug), Digitek (heart failure), Byetta (for Type II diabetes), Ortho Evra (for birth control), and Seroquel (for dimentia, bipolar disorder), please contact Ed Wallis today at (901) 527-2125 or fill out this form today:

Your Name (required)

Your Email (required)

Subject

Your Message

Leave Comment